Cholangiocarcinomas Completed Phase 2 Trials for Carboplatin (DB00958)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00660140Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder CancerTreatment